AstraZeneca: Amgen leaves AstraZeneca alone with brodalumab

NEUTRAL, Fair Value 4830p vs. 4860p (+8%)
News published on May Tuesday 26, 2015
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities